N/A
Completed N=103
Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up
Source: ClinicalTrials.gov NCT01412554 ↗Enrolled (actual)
103
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Exploring Insulin Sensitivity After 10-20 Years of Follow-up — 7 mg/kg/min — p=<0.05
Summary
The purpose of this study is to identify risk factors for insulin resistance and to investigate the influence of insulin sensitivity on development of cardiovascular risk markers like blood pressure, heart rate, body build (weight, BMI, waist-hip ratio, skinfold thickness), reduced insulin sensitivity, diabetes mellitus, dyslipidaemia, and sympathoadrenal activity or manifest cardiovascular disease among young men during 10-20 years.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Exploring Insulin Sensitivity After 10-20 Years of Follow-up |
— | — |
| SECONDARY Sympathoadrenal Activity During Rest and Stress Tests |
— | — |
| SECONDARY Echocardiography |
— | — |
| SECONDARY Ultrasound Abdomen |
— | — |
Eligibility Criteria
Inclusion Criteria
- Completed hyperinsulinemic glucose clamp
Exclusion Criteria
- Missing agreement
- No contact information
Data sourced from ClinicalTrials.gov (NCT01412554). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.